Article Details

Revolo Biotherapeutics Announces Clinical Trial Authorization to Initiate Phase 2 Trial of '1104 in ...

Retrieved on: 2021-07-30 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Revolo Biotherapeutics Announces Clinical Trial Authorization to Initiate Phase 2 Trial of '1104 in .... View article details on hiswai:

Excerpt

Revolo Biotherapeutics is developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up